Cyclic AMP-response element regulated cell cycle arrests in cancer cells.

Recently, we have demonstrated that trichosanthin (TCS), a promising agent for the treatment of cervical adenocarcinoma, inhibited HeLa cell proliferation through the PKC/MAPK/CREB signal pathway. Furthermore, TCS down-regulated Bcl-2 expression was abrogated by a decoy oligonucleotide (OGN) to the...

Full description

Bibliographic Details
Main Authors: Ping Wang, Shuaishuai Huang, Feng Wang, Yu Ren, Michael Hehir, Xue Wang, Jie Cai
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3696002?pdf=render
id doaj-b20c6cf1971d4cfca19b503a0b423a22
record_format Article
spelling doaj-b20c6cf1971d4cfca19b503a0b423a222020-11-25T01:19:17ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0186e6566110.1371/journal.pone.0065661Cyclic AMP-response element regulated cell cycle arrests in cancer cells.Ping WangShuaishuai HuangFeng WangYu RenMichael HehirXue WangJie CaiRecently, we have demonstrated that trichosanthin (TCS), a promising agent for the treatment of cervical adenocarcinoma, inhibited HeLa cell proliferation through the PKC/MAPK/CREB signal pathway. Furthermore, TCS down-regulated Bcl-2 expression was abrogated by a decoy oligonucleotide (OGN) to the cyclic AMP-responsive element (CRE). The decoy OGN blocked the binding of CRE-binding protein (CREB) to Bcl-2. These results suggested that CRE-mediated gene expression may play a pivotal role in HeLa cell proliferation. However, little is known about the effect of TCS on cell cycle arrests, particularly, whether the genes involved in cell cycle were regulated by CRE. Our present study shows that the arrests of S, G1 and G2/M phases were accompanied by the significant down-regulation of cyclin A, D1 and CDK 2, 4 in HeLa cells, cyclin D1, E and CDK 2, 4 in Caski and C33a cells, and cyclin A, B1, E and CDK 2 in SW1990 cells. However, the cell cycle arrests were reversed via the significant up-regulation of cyclin A and D1, by the combined treatment of TCS and CRE. In conclusion, these data demonstrate for the first time that specific cell cycle arrests in cancer cells can be induced by TCS by inhibiting the binding of CREB to CRE on genes related to cell proliferation.http://europepmc.org/articles/PMC3696002?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Ping Wang
Shuaishuai Huang
Feng Wang
Yu Ren
Michael Hehir
Xue Wang
Jie Cai
spellingShingle Ping Wang
Shuaishuai Huang
Feng Wang
Yu Ren
Michael Hehir
Xue Wang
Jie Cai
Cyclic AMP-response element regulated cell cycle arrests in cancer cells.
PLoS ONE
author_facet Ping Wang
Shuaishuai Huang
Feng Wang
Yu Ren
Michael Hehir
Xue Wang
Jie Cai
author_sort Ping Wang
title Cyclic AMP-response element regulated cell cycle arrests in cancer cells.
title_short Cyclic AMP-response element regulated cell cycle arrests in cancer cells.
title_full Cyclic AMP-response element regulated cell cycle arrests in cancer cells.
title_fullStr Cyclic AMP-response element regulated cell cycle arrests in cancer cells.
title_full_unstemmed Cyclic AMP-response element regulated cell cycle arrests in cancer cells.
title_sort cyclic amp-response element regulated cell cycle arrests in cancer cells.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2013-01-01
description Recently, we have demonstrated that trichosanthin (TCS), a promising agent for the treatment of cervical adenocarcinoma, inhibited HeLa cell proliferation through the PKC/MAPK/CREB signal pathway. Furthermore, TCS down-regulated Bcl-2 expression was abrogated by a decoy oligonucleotide (OGN) to the cyclic AMP-responsive element (CRE). The decoy OGN blocked the binding of CRE-binding protein (CREB) to Bcl-2. These results suggested that CRE-mediated gene expression may play a pivotal role in HeLa cell proliferation. However, little is known about the effect of TCS on cell cycle arrests, particularly, whether the genes involved in cell cycle were regulated by CRE. Our present study shows that the arrests of S, G1 and G2/M phases were accompanied by the significant down-regulation of cyclin A, D1 and CDK 2, 4 in HeLa cells, cyclin D1, E and CDK 2, 4 in Caski and C33a cells, and cyclin A, B1, E and CDK 2 in SW1990 cells. However, the cell cycle arrests were reversed via the significant up-regulation of cyclin A and D1, by the combined treatment of TCS and CRE. In conclusion, these data demonstrate for the first time that specific cell cycle arrests in cancer cells can be induced by TCS by inhibiting the binding of CREB to CRE on genes related to cell proliferation.
url http://europepmc.org/articles/PMC3696002?pdf=render
work_keys_str_mv AT pingwang cyclicampresponseelementregulatedcellcyclearrestsincancercells
AT shuaishuaihuang cyclicampresponseelementregulatedcellcyclearrestsincancercells
AT fengwang cyclicampresponseelementregulatedcellcyclearrestsincancercells
AT yuren cyclicampresponseelementregulatedcellcyclearrestsincancercells
AT michaelhehir cyclicampresponseelementregulatedcellcyclearrestsincancercells
AT xuewang cyclicampresponseelementregulatedcellcyclearrestsincancercells
AT jiecai cyclicampresponseelementregulatedcellcyclearrestsincancercells
_version_ 1725139078607798272